Leerink Partnrs Predicts Increased Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Investment analysts at Leerink Partnrs increased their FY2028 earnings per share (EPS) estimates for shares of Henry Schein in a research report issued to clients and investors on Monday, May 5th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $6.25 per share for the year, up from their prior estimate of $6.00. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share.

A number of other equities analysts also recently weighed in on HSIC. Barrington Research decreased their target price on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday. UBS Group dropped their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Wells Fargo & Company reduced their target price on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a report on Tuesday. Piper Sandler decreased their target price on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research report on Wednesday, April 30th. Finally, Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $79.30.

Henry Schein Stock Up 0.5 %

NASDAQ:HSIC opened at $66.57 on Wednesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm’s 50-day moving average price is $67.66 and its 200-day moving average price is $71.48. The company has a market capitalization of $8.16 billion, a PE ratio of 27.40, a P/E/G ratio of 2.13 and a beta of 0.87. Henry Schein has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue for the quarter was down .1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.10 earnings per share.

Insider Activity

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.08% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in HSIC. Invesco Ltd. lifted its holdings in Henry Schein by 0.4% during the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock valued at $343,468,000 after purchasing an additional 17,552 shares in the last quarter. FMR LLC lifted its stake in shares of Henry Schein by 6.6% during the 4th quarter. FMR LLC now owns 3,498,033 shares of the company’s stock valued at $242,064,000 after buying an additional 217,143 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Henry Schein by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock worth $218,762,000 after buying an additional 14,876 shares during the period. Palestra Capital Management LLC bought a new position in Henry Schein in the 4th quarter worth $182,988,000. Finally, Fiduciary Management Inc. WI increased its stake in Henry Schein by 7.2% in the 4th quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company’s stock worth $172,193,000 after buying an additional 167,990 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.